Focus:
Total pharma industry deals for April 2019 worth $7.3bn were announced globally, according to GlobalData's deals database. Embed this chart Embed this chart into your website Copy and paste the...
North America's pharma industry saw a rise of 5.9% in deal activity during April 2019, when compared with the last 12-month average, according to GlobalData's deals database. Embed this chart...
The US pharma industry saw a rise of 7.5% in overall deal activity during April 2019, when compared with the last 12-month average, according to GlobalData's deals database. Embed this...
Total pharma industry M&A deals in April 2019 worth $4.1bn were announced globally, according to GlobalData's deals database. Embed this chart Embed this chart into your website Copy and paste...
Total pharma industry M&A deals in April 2019 worth $3.33bn were announced in the US, according to GlobalData's deals database. Embed this chart Embed this chart into your website Copy...
Total pharma industry deals for March 2019 worth $9.75bn were announced globally, according to GlobalData's deals database. Embed this chart Embed this chart into your website Copy and paste the...
Total pharma industry deals for Q1 2019 worth $143.29bn were announced globally, according to GlobalData's deals database. Embed this chart Embed this chart into your website Copy and paste the...
Europe's pharma industry saw a drop of 11.1% in deal activity during March 2019, when compared with the last 12-month average, according to GlobalData's deals database. Embed this chart Embed...
Total pharma industry M&A deals in March 2019 worth $7.44bn were announced globally, according to GlobalData's deals database. Embed this chart Embed this chart into your website Copy and paste...
The US pharma industry saw a drop of 1.3% in overall deal activity during March 2019, when compared with the last 12-month average, according to GlobalData's deals database. Embed this...
